Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bryophyllum pinnatum vs Solifenacin in Overactive Bladder (BryoSoliP)
NCT02129816Phase 3Terminated
- Sponsor
- University of Zurich
- Start
- May 2014
- Primary completion
- Apr 2016
- Countries
- 1
01
Overview
A Phase 3 trial of Bryophyllum pinnatum in overactive bladder (OAB), urge urinary incontinence (UUI), sponsored by University of Zurich. Started May 2014; status: terminated.
02
Drugs
Bryophyllum pinnatum
03
Conditions
overactive bladder (OAB)urge urinary incontinence (UUI)
Beyond the preview
Go deeper on NCT02129816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02129816.